Cargando…
High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma: Predictors of long-term outcome
BACKGROUND & OBJECTIVES: Survival of patients with multiple myeloma (MM) has improved in the past two decades following use of novel agents and autologous stem cell transplantation. To determine predictors of long-term outcome, data of MM patients who underwent autologous stem cell transplantati...
Autores principales: | Kumar, Lalit, Ramavath, Dev, Kataria, Babita, Tiwari, Akash, Raj, Abhishek, Chellapuram, Santosh Kumar, Mookerjee, Anjali, Sahoo, Ranjit Kumar, Malik, Prabhat S., Sharma, Atul, Gupta, Ritu, Sharma, Om dutt, Biswas, Ahitagni, Kumar, Rakesh, Thulkar, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755776/ https://www.ncbi.nlm.nih.gov/pubmed/31496525 http://dx.doi.org/10.4103/ijmr.IJMR_1593_18 |
Ejemplares similares
-
Induction Therapy with Novel Agents and Autologous Stem Cell Transplant Overcomes the Adverse Impact of Renal Impairment in Multiple Myeloma
por: Kumar, Lalit, et al.
Publicado: (2019) -
Complete response after autologous stem cell transplant in multiple myeloma
por: Kumar, Lalit, et al.
Publicado: (2014) -
Long-Term Outcomes and Safety Trends of Autologous Stem-Cell Transplantation in Non-Hodgkin Lymphoma: A Report From A Tertiary Care Center in India
por: Kumar, Sudhir, et al.
Publicado: (2022) -
Engraftment Syndrome: A Retrospective Analysis of the Experience at a Tertiary Care Institute
por: Pramanik, Raja, et al.
Publicado: (2019) -
Primary CNS Lymphoma in India: A 17-Year Experience From the All India Institute of Medical Sciences
por: Patekar, Mukesh, et al.
Publicado: (2019)